Presentation

0 Comments

15 December 2016

Oral Antiplatelet Agents in PCI

Stronger Agents for All, Tailored Therapy, or Both?

Prof. Paul Gurbel

Previous | Next
Download

Summary

Paul Gurbel, associate professor of medicine at Sinai Center for Thrombosis Research, Johns Hopkins University, discusses the use of oral antiplatelets for patients undergoing PCI. He discusses the mechanism of action of antiplatelet agents and the role of platelet reactivity testing, in research studies and clinical practice. The results of a number of trials are discussed, including those investigating the use of tailored therapy in patients undergoing PCI.

Download

Summary

Paul Gurbel, associate professor of medicine at Sinai Center for Thrombosis Research, Johns Hopkins University, discusses the use of oral antiplatelets for patients undergoing PCI. He discusses the mechanism of action of antiplatelet agents and the role of platelet reactivity testing, in research studies and clinical practice. The results of a number of trials are discussed, including those investigating the use of tailored therapy in patients undergoing PCI.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In